EXJADE 125 mg, comprimé dispersible

Business Listing - September 04, 2021

EXJADE 125 mg, comprimé dispersible

EXJADE 125 mg, comprimé dispersible comprimé dispersible orale Autorisation active Procédure centralisée Non commercialisée 8/28/2006 NOVARTIS EUROPHARM (IRLANDE)

Tags & Categories

active comprimé autorisation procédure commercialisée orale novartis centralisée dispersible exjade

Featured

This is a premium business listing. Stand out from the competition!

Own a Business?

List your company and reach more customers today.

Add Your Business